Barry D Quart's Net Worth

$9.93 Million

Estimate Recalculated May 7, 2024 03:48PM EST

Who is Barry D Quart?

Barry D Quart has an estimated net worth of $9.93 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., HERON THERAPEUTICS, INC. /DE/, SYNAGEVA BIOPHARMA CORP, and Ardea Biosciences, Inc./DE.

SEC CIK

Barry D Quart's CIK is 0001384243

Past Insider Trading and Trends

2022 was Barry D Quart's most active year for acquiring shares with 13 total transactions. Barry D Quart's most active month to acquire stocks was the month of May. 2009 was Barry D Quart's most active year for disposing of shares, totalling 22 transactions. Barry D Quart's most active month to dispose stocks was the month of May. 2018 saw Barry D Quart paying a total of $2,055,400.52 for 571,282 shares, this is the most they've acquired in one year. In 2012 Barry D Quart cashed out on 903,348 shares for a total of $15,777,936.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $18.17

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5K
—
—
5K
Jun 29
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
$8.87
-$319,723.04
0
Nov 29
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 29
Form 3
—
0
—
—
0
No matching records found

HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $2.265

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 18
Form 4
+10.02%
16.2K
$3.22
-$16,544.23
177.99K
Oct 31 - Jan 13
Form 4
+9.88%
14.55K
$3.76
-$19,623.44
161.79K
Oct 13
Form 4
+12.24%
16.05K
$3.43
-$15,709.19
147.24K
Apr 29 - Jul 13
Form 4
+12.47%
14.55K
$6.07
-$31,679.33
131.18K
Apr 13
Form 4
+14.25%
14.55K
$8.30
-$43,317.70
116.64K
Jan 13
Form 4
+2.70%
2.68K
$10.55
-$10,159.65
102.09K
Oct 13
Form 4
+4.42%
4.21K
$13.69
-$12,981.24
99.4K
Apr 30 - Jul 13
Form 4
+3.57%
3.28K
$16.66
-$16,043.58
95.19K
Jun 20 - Apr 13
Form 4
+3.01%
2.68K
$18.16
-$17,488.08
91.91K
Jan 13
Form 4
+1.31%
1.16K
$12.12
$14,036.12
89.23K
Apr 30 - Oct 13
Form 4
—
0
—
—
0
Dec 19
Form 4
+6.02%
5.38K
$17.64
$94,845.47
94.65K
Apr 30 - Oct 3
Form 4
—
0
—
—
0
Dec 15
Form 4
+28.27%
19.68K
$7.20
$141,660.00
89.28K
Sep 14
Form 4
+2.36%
1.61K
$24.12
-$1,478,759.48
69.6K
Scheduled
Apr 30 - Jun 21
Form 4
—
0
$18.48
-$2,255,000.00
67.99K
Scheduled
Mar 19
Form 4
—
0
$15.98
-$1,755,000.00
67.99K
Scheduled
Mar 14
Form 4
+2.54%
1.68K
$12.62
$21,256.29
67.99K
Apr 28 - Dec 18
Form 4
—
0
—
—
0
Dec 21
Form 4
+8.99%
5.47K
$8.89
$48,589.49
66.31K
Apr 29 - Jul 19
Form 4
+6.05%
3.47K
$7.20
$24,998.40
60.84K
Mar 2
Form 4
+2.89%
2.31K
$7.20
$16,668.00
82.37K
Dec 28
Form 4
—
0
—
—
0
Dec 22
Form 4
+14.27%
10K
$7.20
$72,000.00
80.06K
Oct 14
Form 4
+25.66%
14.31K
$7.20
$103,003.20
70.06K
Sep 29
Form 4
+30.05%
12.88K
$7.29
$93,895.60
55.75K
Apr 30 - Aug 18
Form 4
-18.92%
-10.00K
$13.07
-$130,727.00
42.87K
Scheduled
Mar 2
Form 4
-14.53%
-8.99K
$7.50
$14,551.68
52.87K
Oct 31 - Dec 12
Form 4
+19.28%
10K
$11.75
$117,500.00
61.85K
Jun 25
Form 4
—
0
—
—
0
Jan 3
Form 4
+2,695.42%
1M
$0.40
$400,000.00
1.04M
Nov 20
Form 4
—
0
—
—
0
May 1
Form 3
—
0
—
—
0
No matching records found

SYNAGEVA BIOPHARMA CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
$62.50
-$103,125.00
0
Scheduled
Jun 20
Form 4
—
0
$56.98
-$66,050.00
0
Scheduled
Jun 17
Form 4
—
0
$53.16
-$60,310.00
0
Scheduled
Jun 12
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 27
Form 4/A
—
0
—
—
0
Dec 20
Form 4
—
0
—
—
0
Dec 20
Form 4
—
0
—
—
0
Sep 22
Form 4
—
0
—
—
0
Jul 21
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
—
—
0
Aug 6
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Aug 14
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 27
No matching records found

Ardea Biosciences, Inc./DE No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-43.35K
$32.00
-$1,387,136.00
0
Jun 19
Form 4
-18.91%
-10.00K
—
—
42.89K
Dec 22
Form 4
-15.90%
-10.00K
—
—
52.89K
Nov 16 - Dec 16
Form 4
—
0
$15.55
-$466,076.00
62.2K
Scheduled
May 9
Form 4
+31.78%
15K
$15.34
-$398,852.00
62.2K
Scheduled
Feb 7 - Feb 9
Form 4
—
0
—
—
0
Dec 14
Form 4
+11.85%
5K
$12.91
-$321,392.00
47.2K
Scheduled
Sep 16 - Dec 10
Form 4
—
0
$12.06
-$326,268.00
41.86K
Scheduled
Aug 9
Form 4
—
0
$12.55
-$432,562.01
41.52K
Scheduled
May 7
Form 4
+92.96%
20K
$9.24
-$188,767.50
41.52K
Scheduled
Feb 8
Form 4
—
0
—
—
0
Dec 16
Form 4
-41.87%
-15.50K
$9.19
-$264,492.50
21.52K
Scheduled
Dec 9 - Dec 11
Form 4
+37.72%
10K
$3.90
$39,000.00
36.51K
Nov 9
Form 4
+60.57%
10K
$11.61
-$346,630.00
26.51K
Scheduled
Aug 11 - Aug 13
Form 4
-28.29%
-7.50K
—
—
19.01K
May 27
Form 4
+23.24%
5K
$9.65
-$267,682.58
26.51K
May 19
Form 4
—
0
—
—
0
Dec 19
Form 4
+32.25%
5K
$3.90
$19,500.00
20.5K
Sep 22
Form 4
+2,982.11%
15K
$3.90
$58,500.00
15.5K
Sep 3
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Dec 21
Form 3
—
0
—
—
0
No matching records found